Jorie Versmissen Selected Research

Jorie Versmissen Research Topics

Disease

16	Hypertension (High Blood Pressure) 05/2022 - 01/2015
10	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2018 - 04/2009
7	Coronary Disease (Coronary Heart Disease) 01/2020 - 11/2008
6	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2019
4	Neoplasms (Cancer) 01/2022 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2015
4	COVID-19 01/2021 - 01/2020
3	Atherosclerosis 05/2018 - 04/2010
3	Xanthomatosis (Xanthoma) 04/2010 - 09/2009
2	Proteinuria 01/2022 - 01/2019
2	Albuminuria 01/2022 - 01/2020
2	Stroke (Strokes) 11/2021 - 01/2015
2	Renal Insufficiency (Renal Failure) 01/2021 - 08/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2019
2	Myocardial Infarction 01/2021 - 11/2008
2	Venous Thromboembolism 01/2020 - 01/2019
2	Leukemia 12/2016 - 06/2016
2	Philadelphia Chromosome 12/2016 - 06/2016
1	Vascular Diseases (Vascular Disease) 11/2021
1	Disease Progression 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 01/2021
1	Pulmonary Arterial Hypertension 03/2020
1	Hemorrhage 01/2020
1	Thrombophilia 01/2020
1	Acute Coronary Syndrome 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Hypertensive Crisis 01/2019
1	Pulmonary Embolism 07/2018
1	Thrombosis (Thrombus) 07/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2016
1	Inflammation (Inflammations) 04/2009
1	Carcinogenesis 07/2006

Drug/Important Bio-Agent (IBA)

8	Antihypertensive Agents (Antihypertensives)IBA 05/2022 - 01/2015
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 11/2008
6	CholesterolIBA 05/2018 - 04/2010
5	Endothelins (Endothelin)IBA 01/2022 - 01/2019
4	LDL Receptors (LDL Receptor)IBA 03/2015 - 12/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2019
3	macitentanIBA 03/2020 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
3	fibrin fragment D (D-dimer)IBA 01/2019 - 07/2018
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 01/2019
2	Angiogenesis InhibitorsIBA 01/2022 - 01/2020
2	ProstaglandinsIBA 01/2022 - 08/2020
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2020
2	Endothelin Receptor AntagonistsIBA 03/2020 - 01/2019
2	SaltsIBA 01/2019 - 01/2015
2	DiureticsIBA 12/2017 - 01/2015
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2010 - 04/2009
2	LDL CholesterolIBA 12/2009 - 04/2009
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	CanrenoneIBA 01/2022
1	Superoxides (Superoxide)IBA 01/2022
1	Perindopril FDA LinkGeneric 11/2021
1	perindopril drug combination indapamideIBA 11/2021
1	Gliclazide (Diamicron)IBA 11/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Dopamine beta-HydroxylaseIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ambrisentan FDA Link 03/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	AngiotensinsIBA 01/2020
1	TicagrelorIBA 01/2020
1	Prasugrel Hydrochloride FDA Link 01/2020
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2020
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2019
1	Fibrinogen (Factor I)FDA Link 12/2018
1	PCSK9 InhibitorsIBA 12/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2016
1	Imatinib Mesylate (Gleevec)FDA Link 12/2016
1	HDL CholesterolIBA 07/2016
1	C-Reactive ProteinIBA 11/2015
1	LipidsIBA 11/2015
1	Dalteparin (Dalteparin Sodium)FDA Link 08/2015
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2015
1	Tinzaparin (Innohep)FDA Link 08/2015
1	Illicit Drugs (Recreational Drugs)IBA 01/2015
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2015
1	Atorvastatin (Lipitor)FDA Link 01/2015
1	Protein Isoforms (Isoforms)IBA 12/2011
1	Apolipoprotein E4IBA 12/2011
1	ApolipoproteinsIBA 12/2011
1	oxidized low density lipoproteinIBA 04/2010
1	Triglycerides (Triacylglycerol)IBA 12/2009
1	Proteins (Proteins, Gene)FDA Link 09/2009
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 09/2009
1	5-Lipoxygenase-Activating ProteinsIBA 04/2009
1	DNA (Deoxyribonucleic Acid)IBA 07/2006

Therapy/Procedure

8	Therapeutics 10/2021 - 12/2011
1	Critical Care (Surgical Intensive Care) 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Percutaneous Coronary Intervention 01/2020
1	Hematopoietic Stem Cell Transplantation 06/2016
1	Drug Tapering 08/2015
1	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2015